Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

2.82
Delayed Data
As of Apr 21
 +0.06 / +2.17%
Today’s Change
0.79
Today|||52-Week Range
3.10
+21.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues20.6M26.5M45.7M52.2M
 
 
 
 
 
Cost of Goods Sold8.8M10.4M18.4M27.5M
 
 
 
 
 
Depreciation And Amortization493.3K1.2M1.6M1.9M
 
 
 
 
 
 
Operating ExpensesGross Income11.4M14.9M25.7M22.9M
 
 
 
 
 
General Expenses32.1M48.3M46.1M47.0M
 
 
 
 
 
Research And Development15.3M18.6M19.7M21.1M
 
 
 
 
 
Total Operating Expenses41.4M59.9M66.1M76.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.8M-33.4M-20.5M-24.1M
 
 
 
 
 
Extraordinary Charge-65.0K-1.7M-31.5K0.00
 
 
 
 
Other Expenses-68.0K-90.1K-50.8K-202.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.8M-35.1M-20.5M-24.2M
 
 
 
 
 
Income Taxes-300.0K-25.0K-175.0K-100.0K
 
 
 
 
 
Net Income-20.5M-35.2M-20.7M-24.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS126.9M130.5M146.6M155.0M
 
 
 
 
 
Shares To Calculate EPS Diluted126.9M130.5M146.6M155.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.27-$0.14-$0.16
 
 
 
 
 
EPS Diluted-$0.16-$0.27-$0.14-$0.16